Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 17805
Country/Region: South Sudan
Year: 2017
Main Partner: RTI International
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USDOD
Total Funding: $0 Additional Pipeline Funding: $1,197,035

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 20,359
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 1,970
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 2,541
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 2,317
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 125
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 6,117
HTS_TST Service Delivery Point by Agg Age (Facility) VMMC: 15+, Negative 2018 735
HTS_TST Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Negative 2018 248
HTS_TST Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Negative 2018 4,704
HTS_TST Sum of Test Result disaggregates 2018 1,602
HTS_TST_POS By Test Result: Positive 2018 1,602
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 148
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 253
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 308
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 13
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 605
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VMMC: 15+, Positive 2018 15
HTS_TST_POS Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Positive 2018 13
HTS_TST_POS Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Positive 2018 248
PMTCT_ART New on ART 2018 141
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 141
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 2,118
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 127
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 121
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 6
PMTCT_STAT By Age (Numerator): Unknown Age 2018 2,118
PMTCT_STAT By Number of known positives: Unknown Age 2018 108
PMTCT_STAT By Number of new negative: Unknown Age 2018 1,970
PMTCT_STAT By Number of new positives: Unknown Age 2018 40
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 2,118
PMTCT_STAT_den By Age (Denominator): Unknown Age 2018 2,230
PP_PREV Age/sex: 15-19 Female 2018 25
PP_PREV Age/sex: 15-19 Male 2018 175
PP_PREV Age/sex: 20-24 Female 2018 200
PP_PREV Age/sex: 20-24 Male 2018 1,400
PP_PREV Age/sex: 25-49 Female 2018 225
PP_PREV Age/sex: 25-49 Male 2018 1,575
PP_PREV Age/sex: 50+ Female 2018 50
PP_PREV Age/sex: 50+ Male 2018 350
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 4,000
PP_PREV Sum of Age/Sex disaggregates 2018 4,000
TX_CURR Aggregated Age/Sex: <15 Female 2018 17
TX_CURR Aggregated Age/Sex: <15 Male 2018 17
TX_CURR Aggregated Age/Sex: 15+ Female 2018 531
TX_CURR Aggregated Age/Sex: 15+ Male 2018 1,707
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 2,272
TX_CURR Sum of Aggregated Age/Sex <15 2018 34
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 2,238
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 2,272
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 3
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 3
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 301
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 1,149
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 1,456
TX_NEW Pregnancy status 2018 141
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 1,456
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 1,591
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 1,193
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 7
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 2
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 7
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 2
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 222
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 56
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 718
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 179
TX_PVLS Numerator: Indication: Routine 2018 954
TX_PVLS Numerator: Indication: Targeted 2018 239
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 9
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 3
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 9
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 3
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 270
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 102
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 985
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 210
TX_PVLS_den Denominator: Indication: Routine 2018 1,273
TX_PVLS_den Denominator: Indication: Targeted 2018 318
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 100
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 484
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 584
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 834
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 143
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 691
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 2,159
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 151
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 1
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 1
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 35
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 114
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 16
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 16
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 505
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 1,622
TX_TB_den Denominator: By Screen Result: Negative 2018 2,008
TX_TB_den Denominator: By Screen Result: Positive 2018 151
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 324
VMMC_CIRC By Age: 20-24 2018 300
VMMC_CIRC By Age: 25-29 2018 300
VMMC_CIRC By Age: 30-49 2018 150
VMMC_CIRC By circumcision technique: Surgical VMMC 2018 750
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2018 750
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2018 750
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2018 300